NCT01279863

Brief Summary

The VRI technology provides a radiation free dynamic image of the lung, by using a combination of well-known technologies, i.e. acoustic sensors, and a proprietary algorithm. The aim of the study is to determine if the VRI examination may contribute to the diagnosis and follow up of pneumonia in children, and therefore reduce the number of chest radiographs and the exposure to ionizing radiation. Children referred by ED for chest x-ray,for the evaluation of pneumonia, will undergo VRI as well. The two modalities will be read independently and then the findings will be compared, in order to asses the potential role of the VRI to the management of pneumonia in children.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2011

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 18, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 19, 2011

Completed
13 days until next milestone

Study Start

First participant enrolled

February 1, 2011

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2012

Completed
Last Updated

August 12, 2011

Status Verified

May 1, 2010

Enrollment Period

6 months

First QC Date

January 18, 2011

Last Update Submit

August 11, 2011

Conditions

Keywords

PneumoniaCoughShortness of breathVRI

Eligibility Criteria

Age3 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Children, 3-18 years old

You may qualify if:

  • Subject's parent or legal guardian, is able and willing to read the Informed Consent, understands the Informed Consent, and provides written Informed Consent for the subject; if the minor child is in fact able to give consent, the minor's consent must be obtained in addition to the consent of the minor's legal guardian.
  • Boy or girl in the age range of 3-18 years.
  • Patient presented with acute respiratory complaints, acute cough, onset of shortness of breath, or fever.
  • Patient referred by ED physician and presented for CXR.

You may not qualify if:

  • Any of the following will exclude the patient from study:
  • Body habitus or skin condition that might prevent the placement of the sound sensors on the back (e.g. severe scoliosis, kyphosis, chest wall deformation, skin lesion on the back or compression fracture);
  • Potentially contagious skin lesion on the back;
  • \. Subject has had lung surgery; 5. Subject was prescribed the CXR for monitoring or follow up of a lung condition that pre-existed the current, acute symptoms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schneider medical center of Israel, Imaging Department

Petah Tikva, Israel

Location

MeSH Terms

Conditions

PneumoniaFeverCoughDyspnea

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract DiseasesBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsRespiration DisordersSigns and Symptoms, Respiratory

Study Officials

  • Liora Kornreich, MD

    Schneider Children's Medical Center, Israel

    PRINCIPAL INVESTIGATOR
  • Gadi Horev, MD

    Schneider Children's Medical Center, Israel

    STUDY CHAIR
  • Michael Schwarz, MD

    Schneider Children's Medical Center, Israel

    STUDY CHAIR
  • Osnat Konen, MD

    Schneider Children's Medical Center, Israel

    STUDY CHAIR
  • Nadine Berkowitz, MD

    Schneider Children's Medical Center, Israel

    STUDY CHAIR
  • Yehezkel Waisman, MD

    Schneider Children's Medical Center, Israel

    STUDY CHAIR

Central Study Contacts

Liora Kornreich, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 18, 2011

First Posted

January 19, 2011

Study Start

February 1, 2011

Primary Completion

August 1, 2011

Study Completion

February 1, 2012

Last Updated

August 12, 2011

Record last verified: 2010-05

Locations